87 related articles for article (PubMed ID: 16955795)
1. [DHEA inhibits apoptosis of murine OB through MAPK signaling pathways independent of either ARs or ERs].
Wang L; Li DJ; Wang WJ; Zhu Y
Fen Zi Xi Bao Sheng Wu Xue Bao; 2006 Aug; 39(4):365-72. PubMed ID: 16955795
[TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone improves murine osteoblast growth and bone tissue morphometry via mitogen-activated protein kinase signaling pathway independent of either androgen receptor or estrogen receptor.
Wang L; Wang YD; Wang WJ; Zhu Y; Li DJ
J Mol Endocrinol; 2007 Apr; 38(4):467-79. PubMed ID: 17446236
[TBL] [Abstract][Full Text] [Related]
3. Dehydroepiandrosterone indirectly inhibits human osteoclastic resorption via activating osteoblastic viability by the MAPK pathway.
Wang YD; Tao MF; Cheng WW; Liu XH; Wan XP; Cui K
Chin Med J (Engl); 2012 Apr; 125(7):1230-5. PubMed ID: 22613593
[TBL] [Abstract][Full Text] [Related]
4. Selective regulation of osteoblastic OPG and RANKL by dehydroepiandrosterone through activation of the estrogen receptor β-mediated MAPK signaling pathway.
Wang YD; Tao MF; Wang L; Cheng WW; Wan XP
Horm Metab Res; 2012 Jun; 44(7):494-500. PubMed ID: 22556124
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of dehydroepiandrosterone and estrogen on bone and uterus in ovariectomized mice.
Wang L; Wang YD; Wang WJ; Li DJ
Osteoporos Int; 2009 Jan; 20(1):79-92. PubMed ID: 18690485
[TBL] [Abstract][Full Text] [Related]
6. Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs.
Williams MR; Ling S; Dawood T; Hashimura K; Dai A; Li H; Liu JP; Funder JW; Sudhir K; Komesaroff PA
J Clin Endocrinol Metab; 2002 Jan; 87(1):176-81. PubMed ID: 11788644
[TBL] [Abstract][Full Text] [Related]
7. [Selective ERβ action of dehydroepiandrosterone for osteoblast cell line].
Wang YD; Lang X; Tao MF; Cheng WW
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):674-7. PubMed ID: 22176992
[TBL] [Abstract][Full Text] [Related]
8. Estradiol inhibits osteoblast apoptosis via promotion of autophagy through the ER-ERK-mTOR pathway.
Yang YH; Chen K; Li B; Chen JW; Zheng XF; Wang YR; Jiang SD; Jiang LS
Apoptosis; 2013 Nov; 18(11):1363-1375. PubMed ID: 23743762
[TBL] [Abstract][Full Text] [Related]
9. Bushen Ningxin Decoction pharmacological serum promotes the proliferation and suppresses the apoptosis of murine osteoblasts through MAPK pathway.
Wang Y; Cui K; Zhao H; Li D; Wang W; Zhu Y
J Ethnopharmacol; 2009 Mar; 122(2):221-6. PubMed ID: 19330912
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
Arnold JT; Liu X; Allen JD; Le H; McFann KK; Blackman MR
Prostate; 2007 Aug; 67(11):1152-62. PubMed ID: 17503469
[TBL] [Abstract][Full Text] [Related]
11. [Estradiol activates MAPK signaling pathway by estrogen induced VEGF and bFGF in endometrial cancer cells].
Lu Y; Jiang S; Zhang J; Song H; Li L
Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):925-31. PubMed ID: 25608994
[TBL] [Abstract][Full Text] [Related]
12. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
13. Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) inhibit the apoptosis in human peripheral blood lymphocytes.
Takahashi H; Nakajima A; Sekihara H
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):261-4. PubMed ID: 15120419
[TBL] [Abstract][Full Text] [Related]
14. An 8-O-4' norlignan exerts oestrogen-like actions in osteoblastic cells via rapid nongenomic ER signaling pathway.
Xiao HH; Gao QG; Ho MX; Zhang Y; Wong KC; Dai Y; Yao XS; Wong MS
J Ethnopharmacol; 2015 Jul; 170():39-49. PubMed ID: 25978953
[TBL] [Abstract][Full Text] [Related]
15. Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1 via distinct phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-dependent pathways in vascular endothelium.
Formoso G; Chen H; Kim JA; Montagnani M; Consoli A; Quon MJ
Mol Endocrinol; 2006 May; 20(5):1153-63. PubMed ID: 16373398
[TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression.
Liu D; Si H; Reynolds KA; Zhen W; Jia Z; Dillon JS
Endocrinology; 2007 Jul; 148(7):3068-76. PubMed ID: 17395704
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibition.
Beloueche-Babari M; Jackson LE; Al-Saffar NM; Workman P; Leach MO; Ronen SM
Cancer Res; 2005 Apr; 65(8):3356-63. PubMed ID: 15833869
[TBL] [Abstract][Full Text] [Related]
18. Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors.
Williams MR; Dawood T; Ling S; Dai A; Lew R; Myles K; Funder JW; Sudhir K; Komesaroff PA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4708-15. PubMed ID: 15356084
[TBL] [Abstract][Full Text] [Related]
19. Dehydroepiandrosterone inhibited the bone resorption through the upregulation of OPG/RANKL.
Wang YD; Wang L; Li DJ; Wang WJ
Cell Mol Immunol; 2006 Feb; 3(1):41-5. PubMed ID: 16549048
[TBL] [Abstract][Full Text] [Related]
20. Anisomycin superinduces annexin V mRNA expression through the ERK1/2 but not the p38 MAP kinase pathway.
Konishi Y; Sato H; Tanaka T
Biochem Biophys Res Commun; 2004 Jan; 313(4):977-83. PubMed ID: 14706638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
